HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) (“HEXO” or the “Company“), a leading producer of high-quality cannabis products, today announced that, following shareholder approval of a consolidation of the common shares of the Company (“Common Shares“) on the basis of a range between two (2) and fourteen (14) existing pre-consolidation Common Shares for every one (1) post-consolidation Common Share (the “Consolidation“) at the annual and special meeting of the shareholders of the Company held on March 8, 2022, it has filed articles of amendment implementing the Consolidation on the basis of fourteen (14) existing pre-consolidation Common Shares for every one (1) post-consolidation Common Share.
HEXO Announces 1-For-14 Share Reverse Stock Split
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, today announced that, following shareholder approval of a consolidation of the
Related Posts
Ligand Pharmaceuticals Sees 2023 Total Core Revenue Of $118M-$122M; Sees Adjusted Diluted EPS Of $3.10-$3.30 In 2023; Ligand Estimates That At End Of 2022 It Will Have $150M Of Cash And Investments Available To Fund Its M&A Initiatives
December 13, 9:34 AM
Executive Management Reviewed Business Model and Growth Drivers Following the Successful Spin-Off of OmniAb, Introduced 2023 Financial Guidance
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that
Analyst Optimistic As OpenAI Reinstates Altman, Boosting Microsoft’s Spot
November 22, 1:24 PM
Microsoft Corp (NASDAQ: MSFT) stock is trading higher Wednesday after, in a dramatic turn of events,
Baozun’s New Line Of Business BBM Provides Solid Q3 Revenue Contribution: Details
November 22, 6:51 AM
Chinese e-commerce solutions provider Baozun Inc (NASDAQ: BZUN) reported a third-quarter FY23 revenue growth of 4.7% year-on-year to RMB1.82 billion ($249.95 million), missing the